Clinical trial Recruiting at 1 site Observational

Innovative surgery for treating complex carotid artery blockages

Official title: A New Surgical Method for Treating Tandem Carotid Lesions: Gao's Triple Eversion Carotid Endarterectomy

Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT06722222 · Data updated 2026-11-12

This study is testing a new type of surgery for people with complicated carotid artery blockages to see if it is safe and works better than older methods.

Quick facts

Study typeObservational
SexAll
Enrollment11 (estimated)
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedSeptember 17, 2021
Main results expectedSeptember 20, 2031
Study endsSeptember 20, 2031
Registry record updatedDecember 13, 2024
Trial IDNCT06722222 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients with tandem carotid lesions and significant carotid artery stenosis, either symptomatic or asymptomatic.

Probably not a fit

Patients with asymptomatic carotid artery stenosis less than 50% or those who do not meet the diagnostic criteria for carotid artery stenosis will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates Gao's triple eversion carotid endarterectomy (GTE-CEA), a novel surgical technique designed to address tandem carotid lesions that traditional carotid endarterectomy cannot effectively treat. The study involves a retrospective review of patient charts from those who underwent GTE-CEA since September 2021, focusing on patients with significant carotid artery stenosis. The goal is to assess the safety and efficacy of this innovative approach in managing complex carotid artery conditions.

Why it matters

Potential benefit: If successful, this technique could provide a new treatment option for patients with complex carotid artery stenosis, potentially improving surgical outcomes.

How similar studies have gone: While traditional carotid endarterectomy has been widely studied, the specific approach of Gao's triple eversion CEA is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Meet the diagnostic criteria for TCL stenosis.
* Above 70% asymptomatic CCA and ICA stenosis or \> 50% symptomatic CAS confirmed by DSA or CTA before surgery

Exclusion Criteria:

* Did not meet the diagnostic criteria for CAS
* Asymptomatic CAS \< 50% (as confirmed by DSA or CTA before surgery)
* With stenosis at the opening of the CCA.

Where it's running

  • the Second Affiliated Hospital of Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.